IFIH1 rs1990760 (A946T) links heightened antiviral signaling to increased autoimmune risk.

The IFIH1 rs1990760 polymorphism represents a key genetic node where innate antiviral defense and autoimmune pathology intersect. The evidence demonstrates that this genetic variant alters the baseline state of the immune system, modifying how it responds to environmental viral challenges.

Clinical and effectiveness evidence

• Type 1 Diabetes and Systemic Autoimmunity: The IFIH1 rs1990760 (Ala946Thr) T allele is a well-established risk factor for type 1 diabetes, systemic lupus erythematosus (SLE), and multiple sclerosis. Large-scale genome-wide association studies (GWAS) consistently identify this variant as a strong genetic modifier of autoimmune susceptibility.
• Variable Association in Thyroid Autoimmunity: In contrast to type 1 diabetes, the genetic association of rs1990760 with autoimmune thyroid diseases (such as Hashimoto's thyroiditis or Graves' disease) is highly inconsistent. Large pediatric and adult European cohort studies have failed to find a statistically significant association, though some smaller pilot studies have reported minor correlations.

Mechanistic explanations

• Gain-of-Function Mutations: Recombinant MDA5 carrying the A946T mutation encoded by the rs1990760 variant exhibits increased ATPase activity in vitro. This biochemical alteration leads to altered filament dynamics on double-stranded RNA (dsRNA).
• Constitutive Interferon Signature: This altered enzymatic activity drives heightened baseline and ligand-induced type I and type III interferon (IFN) signaling, as well as chronic up-regulation of downstream interferon-stimulated genes (ISGs).
• Lowering the Autoimmune Threshold: Knock-in mouse models carrying this orthologous variant confirm a systemic, low-grade interferon signature. This baseline hyperactivation effectively primes the innate immune system. While this heightened response restricts viral replication, it lowers the immunological threshold required to break self-tolerance, facilitating autoimmune initiation.
• Viral Triggers: Environmental viral infections (such as enteroviruses) act as key triggers. In carriers of the rs1990760 variant, the combination of heightened baseline IFN signaling and active viral infection can promote a feed-forward inflammatory loop, contributing to viral persistence and localized tissue damage.

Bottom line

• The IFIH1 rs1990760 (A946T) variant is a functional gain-of-function polymorphism that heightens antiviral innate immune signaling. This baseline inflammatory priming protects against viral replication but concurrently increases the risk of breaking immunological tolerance, establishing a direct mechanistic link to systemic autoimmune diseases like type 1 diabetes.